KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Other Non Operating Income (2016 - 2026)

Bristol Myers Squibb has reported Other Non Operating Income over the past 18 years, most recently at -$32.0 million for Q1 2026.

  • Quarterly Other Non Operating Income rose 90.56% to -$32.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$367.0 million through Mar 2026, up 68.11% year-over-year, with the annual reading at -$674.0 million for FY2025, 24.52% up from the prior year.
  • Other Non Operating Income was -$32.0 million for Q1 2026 at Bristol Myers Squibb, down from $51.0 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $413.0 million in Q1 2023 and troughed at -$649.0 million in Q1 2022.
  • The 5-year median for Other Non Operating Income is -$32.0 million (2026), against an average of -$59.8 million.
  • Year-over-year, Other Non Operating Income tumbled 14300.0% in 2022 and then surged 163.64% in 2023.
  • A 5-year view of Other Non Operating Income shows it stood at $217.0 million in 2022, then soared by 70.97% to $371.0 million in 2023, then crashed by 182.21% to -$305.0 million in 2024, then soared by 116.72% to $51.0 million in 2025, then plummeted by 162.75% to -$32.0 million in 2026.
  • Per Business Quant, the three most recent readings for BMY's Other Non Operating Income are -$32.0 million (Q1 2026), $51.0 million (Q4 2025), and $108.0 million (Q3 2025).